Clinical features of pediatric post-acute COVID-19: a descriptive retrospective follow-up study

Liene Smane1,2, Ieva Roge3, Zanda Pucuka3,4

  • 1Children's Clinical University Hospital, Riga, Latvia. Liene.Smane@rsu.lv.

Insights

Nearly half of children and adolescents experience persistent COVID-19 symptoms like tiredness and headaches for up to three months post-recovery. This highlights the need for ongoing pediatric COVID-19 monitoring.

Area of Science:

  • Pediatric Infectious Diseases
  • Post-COVID Conditions
  • Adolescent Health

Background:

  • Limited data exists on long-term sequelae of COVID-19 in pediatric populations.
  • A retrospective study analyzed 92 patients aged 18 years or younger.
  • Data was collected 1-3 months post-COVID-19 onset via a specialized assessment protocol.

Discussion:

  • Nearly half (51%) of pediatric patients reported persistent symptoms post-COVID-19.
  • Common symptoms included tiredness, loss of taste/smell, and headaches.
  • Older children (10-18 years) showed a higher prevalence of post-acute symptoms.

Key Insights:

  • COVID-19 can lead to persistent symptoms in children and adolescents.
  • Tiredness, sensory changes, and headaches are prevalent post-acute sequelae.
  • Age appears to influence the manifestation of long-term COVID-19 symptoms.

Outlook:

  • Multidisciplinary follow-up is crucial for all pediatric COVID-19 patients, regardless of initial symptom severity.
  • Further research is needed to understand the long-term trajectory and management of post-COVID conditions in youth.
  • Establishing comprehensive care pathways for pediatric long COVID is essential.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
721
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
529
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
43
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
449
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
37